Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Purple Biotech Ltd. Sponsored ADR (PPBT) had Stock-Based Compensation of $0.31M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-26.39M |
|
-- |
|
-- |
|
$27.46M |
|
$-27.46M |
|
$0.97M |
|
$-26.49M |
|
$-26.49M |
|
$-26.49M |
|
$-26.49M |
|
$-26.49M |
|
$-26.49M |
|
$-27.46M |
|
$-27.25M |
|
0.48M |
|
0.48M |
|
$-54.96 |
|
$-54.96 |
|
| Balance Sheet Financials | |
$9.87M |
|
$0.12M |
|
$7.71M |
|
$17.57M |
|
$7.75M |
|
-- |
|
$0.16M |
|
$7.91M |
|
$9.66M |
|
$2.30M |
|
$9.66M |
|
0.93M |
|
| Cash Flow Statement Financials | |
$-5.66M |
|
$0.63M |
|
$6.33M |
|
$7.40M |
|
$8.72M |
|
$1.32M |
|
|
Stock-Based Compensation |
$0.31M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.27 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-274.27% |
|
-1152.33% |
|
-150.76% |
|
-274.27% |
|
$10.40 |
|
$-11.79 |
|
$-11.78 |
|